UBS analyst Graham Doyle upgraded GE HealthCare (GEHC) to Neutral from Sell with a $73 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Johnson & Johnson Stock (JNJ) Perks Up as it Mulls $2.5B Purchase of Sonic Beam Cancer Fighting MedTech
- GE HealthCare announces intended expansion of radiation oncology portfolio
- GE HealthCare participates in a conference call with JPMorgan
- Strong Q1 Performance and Strategic Initiatives Drive Buy Rating for GE Healthcare Technologies Inc
- GE HealthCare price target lowered to $89 from $103 at Wells Fargo
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue